Dshea 2.0

FDA & Pharmavite join speaker roster for the DSHEA Summit

13-Dec-2023 By Stephen Daniells

Dr Cara Welch, Director of FDA’s Office of Dietary Supplements Programs, and Christine Burdick-Bell, EVP & General Counsel at Pharmavite, have confirmed their participation in the NutraIngredients-USA’s landmark DSHEA Summit.

Announcing the DSHEA Summit: A landmark event bringing together the architects of the law & leading industry voices

04-Dec-2023 By Stephen Daniells

Join Scott Bass, Loren Israelsen, Bob Durkin, Jim Emme, and more industry luminaries for NutraIngredients-USA’s landmark DSHEA Summit.

CRN at 50: Our underlying values haven’t changed

18-Sep-2023 By Stephen Daniells

As the Council for Responsible Nutrition celebrates its 50th anniversary, NutraIngredients-USA caught up with Steve Mister, CRN President and CEO, to hear about the association’s history, its commitment to its founding values, and how it is gearing up...

Trades weigh in on call to clean up dietary supplement industry

31-Mar-2023 By Asia Sherman

In a recent letter to Congress, supplement company Ritual urged lawmakers to clean up a dietary supplement industry that has grown twenty-fold since the enactment of the Dietary Supplement Health and Education Act nearly 30 years ago.

FDA proposes mandatory product listing, industry stakeholders divided

29-Mar-2022 By Danielle Masterson

The fiscal year 2023 budget request marks a 34% increase and highlights immediate priorities, including modernizing DSHEA.

Ex-Health Canada NHP DG on product registration: ‘You have to ask yourself why you are doing it’

05-Aug-2021 By Stephen Daniells

As the conversation around modernizing DSHEA hots up in the US and calls for a mandatory product registration intensify, we caught up with the former Director General of Health Canada’s NHP Directorate to hear about his experiences regulating Natural...

FDA’s Welch on DSHEA 2.0: ‘We have an opportunity for real, common sense reform that I don’t believe we can let pass by’

25-May-2021 By Stephen Daniells

“FDA is not looking to throw out DSHEA and start fresh – rather we are talking about building on the current framework,” said FDA’s Dr Cara Welch. Done correctly, initiatives like a mandatory product listing would not impose significant burdens on the...

UNPA's Israelsen on DSHEA 2.0 & CBD: ‘Unless there is unity, it just gets harder’

29-Apr-2021 By Stephen Daniells

Proposed modernizations to the Dietary Supplement Health and Education Act (DSHEA) and solutions to the CBD issue require “an outstanding effort by industry to speak with a united voice”, says Loren Israelsen, President of the United Natural Products...

AHPA's McGuffin on DSHEA 2.0, CBD's path forward, and more

20-Apr-2021 By Stephen Daniells

While AHPA supports H.R.841, the association wishes FDA “would do its job and establish a legal pathway [for hemp and CBD], but they haven’t,” said Michael McGuffin. “Something needs to happen.”

CRN’s Mister on the best solution for CBD, DSHEA 2.0, and more

14-Apr-2021 By Stephen Daniells

The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act represents ‘the best way’ to deal with the hemp-CBD issue for dietary supplements, says CRN’s Steve Mister, and once that’s clarified then the FDA and industry can address...